Can two therapies heal the hidden wounds of war?

NCT ID NCT07710521

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests two psychological treatments—Acceptance and Commitment Therapy for Moral Injury (ACT-MI) and Present Centered Therapy for Moral Injury (PCT-MI)—in 180 veterans who have experienced moral injury from warzone deployment. The goal is to see which therapy better helps veterans regain daily functioning and reduce distress. Participants attend 15 virtual sessions over 15 weeks and are followed for three months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
two talk therapies: Acceptance and Commitment Therapy for Moral Injury (ACT-MI) and Present Centered Therapy for Moral Injury (PCT-MI)
What this could lead to
If one therapy proves more effective, it could become a standard treatment for moral injury in veterans, improving their daily lives and relationships.
What could go wrong
This is a relatively small, early-stage trial with 180 participants, so results may not apply to all veterans. Both therapies may show similar benefits, or neither may lead to lasting improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORAL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rocky Mountain VA Regional Medical Center

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.